Spearheading Induced Proximity Drugs Towards Clinical Approval

Accelerating the Discovery, Development & Approval of First-In-Class Selective, Safe & Efficacious Degraders & Proximity-Based Drugs to Target the Undruggable

After a decade of innovation, the TPD field has its first drug approval in the form of Arvinas’ Veppanu. Combined with the recovering market of 2026, this clinical validation will unleash a new wave of innovative approaches and push TPD to a new inflection point. Already, the headwinds are reversing with $15B worth of upfront deals involving TPD candidates and companies in 2026 alone.

However, following the risk-averse funding environment of 2025, continued positive clinical data is key to regaining investor confidence and pharma interest. That’s why the 9th TPD & Induced Proximity Summit is returning as the globe’s definitive forum to help you gain that ever-important clinical validation. As the world’s largest and most comprehensive TPD conference featuring the latest data from early discovery to clinical development, it is designed to help you discover the best novel targets, optimize your degrader profile, and accelerate your pipelines to the clinic and beyond.

In the rapidly advancing field of TPD research, this summit is an excellent opportunity to see a number of amazing cutting-edge approaches from academia, biotech and pharma.

Kazuteru Aoki, Vice President of Biology, FIMECS, Inc.

logo (5)

In a rapidly evolving drug development landscape, engaging with global experts at the TPD Summit is not just an opportunity—it’s a strategic imperative to validate and sharpen the competitive edge of our protein degrader platform.

Hyunson Jo, Founder and CEO, Pin Therapeutics

1622573510308

The TPD&IP Summit is THE meeting each year to learn from the best and brightest minds working on PROTACs, DACs, and molecular glues -- it is THE not-miss meeting to stay on top of this rapidly evolving field.

Brent Meadows, CBO, Polymed Bio

1719256208661

What To Expect

300+

Attendees

80+

World-Class Speakers

30+

C-Level
Speakers

15+

Hours of In-Person Networking

3

Dedicated Tracks of Content

1

Chance to be at the World's leading TPD event

Attending Companies Include

Join Biopharma Experts
Explore the 2025 Agenda

Hear the latest industry breakthroughs and gain exclusive insights on the TPD innovations during our packed agenda, interactive roundtables, and new CCOs & VC panel discussions.

Partner With Us
Partner With Us

Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.

Explore the Agenda
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.